Moxifloxacin‐containing 4‐month ATT regimens vs standard 6‐month ATT regimen
Acquired drug resistance · adults with drug‐sensitive pulmonary tuberculosis
Moxifloxacin‐containing 4‐month ATT regimens showed no clear difference in acquired drug resistance compared with standard 6‐month ATT regimen (low certainty).
1 finding from 1 review
- Shortened treatment regimens versus the standard regimen for drug‐sensitive pulmonary tuberculosis 2019 · Cochrane Headline outcomes onlyRR 0.33 [0.08, 1.31]3 studies · 2282 participantsLow